Ra Capital Management, L.P. has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $5.82 Billion distributed in 68 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $2.04B, Rhythm Pharmaceuticals, Inc. with a value of $574M, Vaxcyte, Inc. with a value of $431M, Avidity Biosciences, Inc. with a value of $376M, and 89bio, Inc. with a value of $292M.
Examining the 13F form we can see an increase of $1.25B in the current position value, from $4.58B to 5.82B.
Ra Capital Management, L.P. is based out at Boston, MA
Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.
